Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evogene Ltd. (EVGN : NSDQ)
 
 • Company Description   
Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.

Number of Employees: 52

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.70 Daily Weekly Monthly
20 Day Moving Average: 62,441 shares
Shares Outstanding: 8.72 (millions)
Market Capitalization: $6.10 (millions)
Beta: 1.39
52 Week High: $2.42
52 Week Low: $0.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.91% -15.26%
12 Week -18.67% -24.81%
Year To Date -36.36% -42.04%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13 GAD FEINSTEIN STREET PARK REHOVOT
-
REHOVOT,L3 7638517
ISR		 ph: 972-8931-1900
fax: 972-8946-6724		 rachel.pomerantz@evogene.com http://www.evogene.com
 
 • General Corporate Information   
Officers
Ofer Haviv - Chief Executive Officer and President
Nir Nimrodi - Chairperson of the Board
Yaron Eldad - Chief Financial Officer
Polina Ravzin - Vice President
Sarit Firon - Director

Peer Information
Evogene Ltd. (CORR.)
Evogene Ltd. (RSPI)
Evogene Ltd. (CGXP)
Evogene Ltd. (BGEN)
Evogene Ltd. (GTBP)
Evogene Ltd. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: M4119S187
SIC: 2870
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/18/26
Share - Related Items
Shares Outstanding: 8.72
Most Recent Split Date: 7.00 (0.10:1)
Beta: 1.39
Market Capitalization: $6.10 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/18/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.76
Price/Cash Flow: -
Price / Sales: 3.31
EPS Growth
vs. Year Ago Period: -57.89%
vs. Previous Quarter: 1.64%
Sales Growth
vs. Year Ago Period: -86.33%
vs. Previous Quarter: 6.37%
ROE
03/31/26 - -158.82
12/31/25 - -121.44
09/30/25 - -75.09
ROA
03/31/26 - -80.37
12/31/25 - -57.34
09/30/25 - -31.82
Current Ratio
03/31/26 - 2.79
12/31/25 - 4.54
09/30/25 - 5.11
Quick Ratio
03/31/26 - -
12/31/25 - 4.48
09/30/25 - 4.59
Operating Margin
03/31/26 - -1,067.84
12/31/25 - -414.62
09/30/25 - -203.28
Net Margin
03/31/26 - -638.12
12/31/25 - -214.57
09/30/25 - -52.33
Pre-Tax Margin
03/31/26 - -949.08
12/31/25 - -350.32
09/30/25 - -169.66
Book Value
03/31/26 - 0.92
12/31/25 - 1.37
09/30/25 - 3.22
Inventory Turnover
03/31/26 - 2.43
12/31/25 - 2.55
09/30/25 - 1.29
Debt-to-Equity
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©